Core Viewpoint - The company is convening the first bondholders' meeting for its convertible bonds, focusing on the proposed change in the use of raised funds to enhance operational efficiency and align with market demands [1][4][16] Meeting Information - The bondholders' meeting is scheduled for July 29, 2025, at 14:30, in Jiangsu Province, Nantong City [2][3] - The agenda includes participant registration, announcement of attendees, reading of meeting guidelines, election of vote counters, and discussion of the proposal to change the investment project [2][3][4] Fundraising Overview - The company raised a total of RMB 617.1 million from the issuance of convertible bonds, with net proceeds amounting to RMB 610.1 million after deducting issuance costs of RMB 7 million [4][5] - As of June 30, 2025, RMB 103.89 million has been invested in projects, with RMB 536.91 million remaining uninvested [5][6] Proposed Change in Investment Project - The company plans to reallocate RMB 195 million (31.81% of net proceeds) from the original project focused on lithium battery anode materials to a new project involving silicon carbide and carbon-based composite anti-corrosion equipment [6][8] - The original project faced challenges due to market conditions, including declining prices and increased competition, prompting the company to slow its implementation [7][8] New Project Details - The new project aims to produce high-performance anti-corrosion equipment for the chemical, energy, and environmental sectors, enhancing the company's product offerings and market competitiveness [8][10] - The project is expected to generate a net profit of RMB 33.27 million, with an internal rate of return of 14.65% and a payback period of 8.9 years [10][11] Strategic Rationale - The shift to the new project aligns with industry trends towards high-efficiency, low-carbon solutions, addressing the limitations of traditional materials in harsh environments [11][12] - The company leverages its strong brand reputation and customer base to support the new project's market entry, ensuring a solid foundation for sales [12][13] Technical and Team Capabilities - The company possesses robust R&D capabilities and a skilled workforce, which are critical for the successful implementation of the new project [13][14] - Continuous innovation and a focus on customer needs position the company to effectively meet market demands and enhance its competitive edge [14][15]

Group 1 - The company is proposing a stock option incentive plan for 2025 to attract and retain talent, aligning the interests of shareholders, the company, and core team members [5][6][8] - The stock option incentive plan has been approved by the company's board and supervisory committee and is now submitted for shareholder approval [6][8] - The company will conduct the shareholder meeting on July 14, 2025, with both on-site and online voting options available [5][7] Group 2 - The company plans to change its name from "Jiangsu Aidea Pharmaceutical Co., Ltd." to "Jiangsu Aidea Pharmaceutical Group Co., Ltd." to enhance group management and resource utilization [12][13] - The name change aligns with the company's strategic development needs and will not adversely affect its operations or shareholder interests [13][14] - The company will also revise its articles of association to reflect the name change and will seek necessary approvals for the changes [14][22] Group 3 - The company intends to adjust its fundraising investment projects, specifically changing the focus from "Ustectidine New Indication Research Project" to "Integrase Inhibitor Drug Research and Clinical Study Project" [16][19] - The total amount of funds to be redirected is approximately 84.37 million yuan, which will be fully allocated to the new project [15][19] - The integrase inhibitor project aims to develop a new generation of anti-HIV drugs and has shown promising results in initial clinical trials [20][21] Group 4 - The company is proposing the appointment of a new independent director candidate, Hu Wenyuan, following the resignation of the previous independent director [11][12] - The nomination has been approved by the board and is now subject to shareholder approval [11][12] - The company is also seeking to fill a vacancy in the supervisory board due to the resignation of a non-employee representative supervisor [22][23]

Core Viewpoint - The company is undergoing a change in the use of part of the raised funds from its initial public offering to enhance operational efficiency and adapt to market demands [1][12][14]. Fundraising Overview - The company successfully issued 31,507,704 shares at a price of 24.18 RMB per share, raising a total of 761.8563 million RMB, with a net amount after expenses [1]. - A verification report was issued by the auditing firm confirming the funds' arrival [1]. Fund Management - The company and its subsidiaries have signed a tripartite supervision agreement for the special account storage of the raised funds to ensure proper management and protection of investors' rights [2]. Investment Project Changes - The company plans to reallocate 19 million RMB from the "Automobile Wheel Assembly Project in Hefei Changfeng" to a new project, which constitutes 2.80% of the net amount raised from the IPO [2][3][6]. - The original project had not utilized the allocated funds, prompting the change to improve fund usage efficiency [3][5]. New Project Details - The new project involves the annual production of 700,000 automotive styling parts, NVH acoustic products, and 3.5 million wheel assemblies, with a total investment of approximately 650 million RMB [7][9]. - The project is set to begin construction in 2024 and aims for production in 2025, with expected gradual revenue generation [7][9]. Market Context - The domestic market for independent brand vehicles is growing, with a reported 20.1% increase in sales for 2024, indicating a favorable environment for the company's new project [9][10]. - The company has established partnerships with major automotive manufacturers, enhancing its market position and customer base [10]. Decision-Making Process - The decision to change the investment project was approved by the board and the supervisory committee, aligning with regulatory requirements and the company's strategic needs [12][14].

Core Viewpoint - Hubei Jianghan New Materials Co., Ltd. has completed the fundraising process for its initial public offering (IPO) and is making changes to its fundraising investment projects and office address [1][2][3]. Group 1: Fundraising and Financial Details - The company was approved to publicly issue 66,666,667 shares at a price of RMB 35.59 per share, raising a total of RMB 2,372,666,678.53, which was fully received by January 19, 2023 [1]. - The funds have been deposited into a special account approved by the board, and a tripartite supervision agreement has been signed with the sponsor and the bank [1]. - The total planned investment for the "Annual Production of 2000 Tons of Aerogel Composite Materials Industrialization Construction Project" was RMB 246,778.01 million, with RMB 205,926.71 million allocated [2]. Group 2: Changes in Investment Projects - The project "Annual Production of 2000 Tons of Aerogel Composite Materials Industrialization Construction Project" has been changed to "Silicon-based New Materials Green Circular Industrial Park Phase I," with remaining funds of RMB 15,193.59 million and accumulated interest to be fully invested in the new project [2]. - The project "Annual Production of 2000 Tons of High-purity Quartz Sand Industrialization Construction Project" has been changed to "Functional New Materials Silicon-based Precursor Project (Phase I)," with remaining funds of RMB 35,038.77 million to be fully invested in the new project [3]. - The new project will be implemented by the wholly-owned subsidiary Hubei Jianghan Electronic Materials Co., Ltd., with RMB 100 million allocated as equity and the remaining funds provided as a loan [3]. Group 3: Project Completion and Office Relocation - The "Research Center and Office Center Construction Project" has reached the predetermined usable state and is set for completion [4]. - The office address has been changed from "36 Qunli Avenue, Shashi Economic Development Zone, Jingzhou City, Hubei Province" to "259 Dongfang Avenue, Shashi District, Jingzhou City, Hubei Province" [5].

Meeting Overview - The third meeting of the Supervisory Board of Jiangsu Aidi Pharmaceutical Co., Ltd. was held on June 27, 2025, with all three supervisors present, confirming the legality and validity of the meeting [1]. Resolutions Passed - The Supervisory Board approved the proposal to cancel part of the unvested restricted stock, stating that it complies with relevant laws and regulations, and does not harm shareholders' interests [1][2]. - The Supervisory Board approved the draft of the 2025 Stock Option Incentive Plan, which aligns with legal requirements and is expected to benefit the company's sustainable development [2][3]. - The Supervisory Board approved the implementation assessment management measures for the 2025 Stock Option Incentive Plan, ensuring smooth execution and alignment with the company's governance structure [3][4]. - The Supervisory Board verified the list of initial incentive objects for the 2025 Stock Option Incentive Plan, confirming their qualifications under relevant laws and regulations [4][5]. - The Supervisory Board approved changes to certain fundraising investment projects and amount adjustments, aimed at enhancing operational stability and profitability [5][6]. - The Supervisory Board agreed to nominate Tang Jieqing as a candidate for a non-employee representative supervisor, pending shareholder approval [6][7]. - The Supervisory Board elected current employee representative supervisor Pang Qiuchen as the chairman of the Supervisory Board, effective immediately [7].

北京百纳千成影视股份有限公司 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 北京百纳千成影视股份有限公司（以下简称"公司"）于 2025 年 5 月 7 日以 电话、电子邮件等方式，向公司各位监事发出关于召开第五届监事会第十六次会 议的通知，并于 2025 年 5 月 12 日在公司会议室以现场与通讯表决相结合的方式 召开。会议由公司监事会主席任扩延先生主持，应出席监事 3 人，实际出席监事 司章程》的规定。 证券代码：300291 证券简称：百纳千成 公告编号：2025-023 本议案尚需提交股东大会审议。 表决结果：全体监事以 3 票同意、0 票反对、0 票弃权通过。 具体内容详见公司在巨潮资讯网（http://www.cninfo.com.cn）披露的《关于 三、备查文件 特此公告。 北京百纳千成影视股份有限公司监事会 二、监事会会议审议情况 会议经审议，通过了如下议案： 《关于 2020 年募集资金投资项目变更并新增募投项目实施主体的议案》。 与会监事一致认为：本次变更募集资金投资项目，是根据公司目前发展的实 际情况做出的审慎 ...